# Hemab Therapeutics

**Canonical:** https://apis.io/providers/hemab-therapeutics/  
**Website:** https://www.hemab.com/  
**APIs profiled:** 0

Hemab Therapeutics is a clinical-stage biopharmaceutical company headquartered in Copenhagen, Denmark with a US presence in Cambridge, Massachusetts, developing prophylactic antibody-based therapeutics for serious, underserved bleeding and thrombotic disorders. Its modality-agnostic approach uses monoclonal and bispecific antibodies to stabilize coagulation proteins, prevent their premature breakdown, and direct them to sites of injury. The clinical pipeline targets Glanzmann Thrombasthenia (sutacimig, HMB-001), von Willebrand Disease (HMB-002), Factor VII deficiency and heavy menstrual bleeding. Hemab publishes a corporate marketing site, an investor relations site, and audience-specific sections for patients, caregivers and healthcare providers. It operates no public developer program: there is no developer portal, API reference, machine-readable specification, SDK, or webhook surface on any host it controls.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 11.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Hemab Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Clinical Trials, Healthcare, Rare Disease, Hematology, Denmark

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/hemab-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.